- Home
- ANIK vs IKT Comparison
ANIK vs IKT Comparison
Compare ANIK & IKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIK
- IKT
- Stock Information
- Founded
- ANIK 1983
- IKT 2008
- Country
- ANIK United States
- IKT United States
- Employees
- ANIK N/A
- IKT N/A
- Industry
- ANIK Medical/Dental Instruments
- IKT Biotechnology: Pharmaceutical Preparations
- Sector
- ANIK Health Care
- IKT Health Care
- Exchange
- ANIK Nasdaq
- IKT Nasdaq
- Market Cap
- ANIK 133.1M
- IKT 111.8M
- IPO Year
- ANIK 1993
- IKT 2020
- Fundamental
- Price
- ANIK $10.01
- IKT $1.53
- Analyst Decision
- ANIK Buy
- IKT Hold
- Analyst Count
- ANIK 1
- IKT 1
- Target Price
- ANIK $16.00
- IKT N/A
- AVG Volume (30 Days)
- ANIK 127.3K
- IKT 102.4K
- Earning Date
- ANIK 11-05-2025
- IKT 11-14-2025
- Dividend Yield
- ANIK N/A
- IKT N/A
- EPS Growth
- ANIK N/A
- IKT N/A
- EPS
- ANIK N/A
- IKT N/A
- Revenue
- ANIK $112,806,000.00
- IKT N/A
- Revenue This Year
- ANIK N/A
- IKT N/A
- Revenue Next Year
- ANIK $4.57
- IKT N/A
- P/E Ratio
- ANIK N/A
- IKT N/A
- Revenue Growth
- ANIK 30.55
- IKT N/A
- 52 Week Low
- ANIK $7.87
- IKT $1.33
- 52 Week High
- ANIK $18.37
- IKT $4.20
- Technical
- Relative Strength Index (RSI)
- ANIK 58.60
- IKT 47.90
- Support Level
- ANIK $9.41
- IKT $1.55
- Resistance Level
- ANIK $10.30
- IKT $1.67
- Average True Range (ATR)
- ANIK 0.38
- IKT 0.13
- MACD
- ANIK 0.01
- IKT 0.01
- Stochastic Oscillator
- ANIK 43.70
- IKT 51.16
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease (PD), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.